105 related articles for article (PubMed ID: 38853188)
1. Dixon MRI-based quantitative parameters of extraocular muscles, intraorbital fat, and lacrimal glands for staging thyroid-associated ophthalmopathy.
Pu XY; Chen L; Hu H; Wu Q; Jiang WH; Lu JL; Chen HH; Xu XQ; Wu FY
Insights Imaging; 2024 Jun; 15(1):136. PubMed ID: 38853188
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of two-point Dixon T2-weighted imaging in thyroid-associated ophthalmopathy: comparison with conventional fat saturation imaging in fat suppression quality and staging performance.
Chen L; Hu H; Chen HH; Chen W; Wu Q; Wu FY; Xu XQ
Br J Radiol; 2021 Feb; 94(1118):20200884. PubMed ID: 33353397
[TBL] [Abstract][Full Text] [Related]
3. Predicting the response to glucocorticoid therapy in thyroid-associated ophthalmopathy: mobilizing structural MRI-based quantitative measurements of orbital tissues.
Hu H; Xu XQ; Chen L; Chen W; Wu Q; Chen HH; Zhu H; Shi HB; Wu FY
Endocrine; 2020 Nov; 70(2):372-379. PubMed ID: 32504380
[TBL] [Abstract][Full Text] [Related]
4. Image quality and evaluation ability of magnetic resonance imaging techniques for thyroid-associated ophthalmopathy: Dixon fat-suppression technique vs. spectral attenuated inversion recovery.
Huang K; Lin X; Luo Y; Hu Q; Guo B; Ouyang F; Ouyang Y; Song C; Chen H
Front Med (Lausanne); 2023; 10():1154828. PubMed ID: 37502355
[TBL] [Abstract][Full Text] [Related]
5. [The value of DCE-MRI in assessing the course of thyroid associated ophthalmopathy].
Wu T; Tang DR; Wang F; Xia S; Sun FY
Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):430-435. PubMed ID: 28606264
[No Abstract] [Full Text] [Related]
6. Prediction of treatment response to intravenous glucocorticoid in patients with thyroid-associated ophthalmopathy using T2 mapping and T2 IDEAL.
Zhai L; Luo B; Wu H; Wang Q; Yuan G; Liu P; Ma Y; Zhao Y; Zhang J
Eur J Radiol; 2021 Sep; 142():109839. PubMed ID: 34252869
[TBL] [Abstract][Full Text] [Related]
7. Whole-orbit-based multiparametric assessment of disease activity of thyroid eye disease on Dixon MRI.
Xia D; Zhang H; Wang H; Jiang M; Tang Y; Li Y; Sun J; Song X; Zhou H
Int Ophthalmol; 2024 May; 44(1):213. PubMed ID: 38700596
[TBL] [Abstract][Full Text] [Related]
8. Correlation between extent of lacrimal gland prolapse and clinical features of thyroid-associated ophthalmopathy: a retrospective observational study.
Gao Y; Chang Q; Li Y; Zhang H; Hou Z; Zhang Z; Li Z; Li D
BMC Ophthalmol; 2022 Feb; 22(1):66. PubMed ID: 35144579
[TBL] [Abstract][Full Text] [Related]
9. Thyroid-Associated Ophthalmopathy: Preliminary Study Using T2 Mapping to Characterize Intraorbital Optic Nerve Changes Before Dysthyroid Optic Neuropathy.
Hu H; Chen HH; Chen W; Wu Q; Chen L; Zhu H; Shi HB; Xu XQ; Wu FY
Endocr Pract; 2021 Mar; 27(3):191-197. PubMed ID: 33630733
[TBL] [Abstract][Full Text] [Related]
10. T
Hu H; Chen L; Zhang JL; Chen W; Chen HH; Liu H; Shi HB; Wu FY; Xu XQ
J Magn Reson Imaging; 2022 Sep; 56(3):862-872. PubMed ID: 35092642
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of orbital soft tissues on computed tomography to assess the activity of thyroid-associated orbitopathy.
Byun JS; Moon NJ; Lee JK
Graefes Arch Clin Exp Ophthalmol; 2017 Feb; 255(2):413-420. PubMed ID: 27838736
[TBL] [Abstract][Full Text] [Related]
12. ROLE OF MAGNETIC RESONANCE IMAGING IN THE ASSESSMENT OF ACTIVE THYROID-ASSOCIATED OPHTHALMOPATHY PATIENTS WITH LONG DISEASE DURATION.
Zhou M; Shen L; Jiao Q; Ye L; Zhou Y; Zhu W; Wang W; Wang S
Endocr Pract; 2019 Dec; 25(12):1268-1278. PubMed ID: 31412229
[No Abstract] [Full Text] [Related]
13. Magnetic resonance imaging with diffusion-weighted imaging in the evaluation of thyroid-associated orbitopathy: getting below the tip of the iceberg.
Politi LS; Godi C; Cammarata G; Ambrosi A; Iadanza A; Lanzi R; Falini A; Bianchi Marzoli S
Eur Radiol; 2014 May; 24(5):1118-26. PubMed ID: 24519110
[TBL] [Abstract][Full Text] [Related]
14. Radiological Staging of Thyroid-Associated Ophthalmopathy: Comparison of T1 Mapping with Conventional MRI.
Chen L; Chen W; Chen HH; Wu Q; Xu XQ; Hu H; Wu FY
Int J Endocrinol; 2020; 2020():2575710. PubMed ID: 33144856
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of extraocular muscles for intraocular pressure in thyroid-associated ophthalmopathy patients.
Tian H; Wang Y; Li J; Li H
Quant Imaging Med Surg; 2023 Sep; 13(9):5727-5736. PubMed ID: 37711835
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of activity of Graves' orbitopathy with multiparameter orbital magnetic resonance imaging (MRI).
Cheng J; Zhang X; Lian J; Piao Z; Zhou L; Gou X; Chen C; Chen L; Jiang K; Cheng J; Ji L; Hong N
Quant Imaging Med Surg; 2023 May; 13(5):3040-3049. PubMed ID: 37179934
[TBL] [Abstract][Full Text] [Related]
17. Diffusion Tensor Imaging Technology to Quantitatively Assess Abnormal Changes in Patients With Thyroid-Associated Ophthalmopathy.
Rui L; Jing L; Zhenchang W
Front Hum Neurosci; 2021; 15():805945. PubMed ID: 35185495
[TBL] [Abstract][Full Text] [Related]
18. Thyroid-Associated Orbitopathy: Evaluating Microstructural Changes of Extraocular Muscles and Optic Nerves Using Readout-Segmented Echo-Planar Imaging-Based Diffusion Tensor Imaging.
Chen HH; Hu H; Chen W; Cui D; Xu XQ; Wu FY; Yang T
Korean J Radiol; 2020 Mar; 21(3):332-340. PubMed ID: 32090526
[TBL] [Abstract][Full Text] [Related]
19. Application of Multiparameter Quantitative Magnetic Resonance Imaging in the Evaluation of Graves' Ophthalmopathy.
Li Z; Luo Y; Feng X; Zhang Q; Zhong Q; Weng C; Chen Z; Shen J
J Magn Reson Imaging; 2023 Oct; 58(4):1279-1289. PubMed ID: 36780178
[TBL] [Abstract][Full Text] [Related]
20. T2 Relaxation Time in Extraocular Muscles of Patients with Mild Thyroid- Associated Ophthalmopathy: Comparing T2 Mapping With and Without Fat Suppression Using Different Measurement Methods.
Li D; Guo X; Zeng J; Feng H; Zhu T; Li H
Curr Med Imaging; 2024 Apr; ():. PubMed ID: 38639286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
